SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation

Maastricht Radiation Oncology864 enrolled

Overview

Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.

All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for genetic profiling. Follow up at five time points: * 2 weeks after RT * 3 months after RT * 6 months after RT * 12 months after RT * 24 months after RT At these time points, toxicity will be assessed. In addition, patients will receive a short questionnaire by mail at eight time points.

Study Type

OBSERVATIONAL

Enrollment

864

Conditions

Lung Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients planned for curatively intended radiotherapy or postoperative radiotherapy * Recurrent disease Exclusion Criteria: * All patients planned for palliative radiotherapy

Locations (1)

MAASTRO clinic

Maastricht, Netherlands

Outcomes

Primary Outcomes

Two-year survival rate

Time frame: 24 months after RT

Secondary Outcomes

Change in dyspnea

Time frame: during 24 months after RT

Change in cough

Time frame: During 24 months after RT

Change in dysphagia

Time frame: During 24 months after RT

Patient-rated generic quality of life

Measured by Euroqol questionnaire

Time frame: During 24 months after RT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.